R. Chovatiya, “Improvement of the Head and Neck Regions with Continuous Tralokinumab treatment for Up to 4 years in Adults with Moderate-to-Severe Atopic Dermatitis”, J of Skin, vol. 8, no. 1, p. s316, Jan. 2024.